Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Long-Term Deferred Tax (2020 - 2021)

Journey Medical (DERM) has disclosed Long-Term Deferred Tax for 2 consecutive years, with $8.4 million as the latest value for Q3 2021.

  • For the quarter ending Q3 2021, Long-Term Deferred Tax changed N/A year-over-year to $8.4 million, compared with a TTM value of $8.4 million through Sep 2021, changed N/A, and an annual FY2020 reading of $1.5 million, changed N/A over the prior year.
  • Long-Term Deferred Tax was $8.4 million for Q3 2021 at Journey Medical, up from $1.5 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $8.4 million in Q3 2021 and bottomed at $1.5 million in Q4 2020.